- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Pegfilgrastim – July 2017
Pegfilgrastim: Injection 6 mg in 0.6 mL single use pre-filled syringe; Neulasta®, Ristempa®
Last updated
10 November 2017